Durable immunity to ricin toxin elicited by a thermostable, lyophilized subunit vaccine
H Novak, J Doering, D Ehrbar, O Donini, NJ Mantis - MSphere, 2021 - Am Soc Microbiol
The development of vaccines against biothreat toxins like ricin (RT) is considered an integral
component of the US national security efforts. RiVax is a thermostable, lyophilized RT …
component of the US national security efforts. RiVax is a thermostable, lyophilized RT …
[HTML][HTML] Vaccine hesitancy towards COVID vaccine among unvaccinated frontline health care workers working in a designated COVID care center: A cross-sectional …
SS Shankar, A Suresh… - Journal of Family …, 2022 - journals.lww.com
Background: Frontline health care workers (FLHCW) like doctors and nurses are bound to
treat COVID patients being themselves not immune to disease are at a greater risk of COVID …
treat COVID patients being themselves not immune to disease are at a greater risk of COVID …
[HTML][HTML] A mRNA vaccine encoding for a RBD 60-mer nanoparticle elicits neutralizing antibodies and protective immunity against the SARS-CoV-2 delta variant in …
P Brandys, X Montagutelli, I Merenkova… - Frontiers in …, 2022 - frontiersin.org
Two years into the COVID-19 pandemic there is still a need for vaccines to effectively control
the spread of novel SARS-CoV-2 variants and associated cases of severe disease. Here we …
the spread of novel SARS-CoV-2 variants and associated cases of severe disease. Here we …
An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged mice
Development of affordable and effective vaccines that can also protect vulnerable
populations such as the elderly from COVID-19-related morbidity and mortality is a public …
populations such as the elderly from COVID-19-related morbidity and mortality is a public …
Role of syrian hamsters and nonhuman primates in covid-19 research
SARS-CoV-2 pandemic has created serious public health issues claiming millions of human
lives worldwide. Few vaccines for the control of COVID-19 are now available under …
lives worldwide. Few vaccines for the control of COVID-19 are now available under …
[PDF][PDF] A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies
MW Chen, SM Lim, SY Ng, PA Tambyah, H Nasir… - academia.edu
Abstract Background Neutralizing antibodies (NAbs) prevent pathogens from infecting host
cells. Detection of SARS-CoV-2 NAbs is critical to evaluate herd immunity and monitor …
cells. Detection of SARS-CoV-2 NAbs is critical to evaluate herd immunity and monitor …
Virus like particles of ssRNA bacteriophages-versatile tools in vaccine development
I Liekniņa - 2021 - dspace.lu.lv
Virus-like particles (VLPs) can be used as efficient carriers of various antigens and therefore
serve as attractive tools in vaccine development. Especially, VLPs of ssRNA phages have …
serve as attractive tools in vaccine development. Especially, VLPs of ssRNA phages have …
Sars-cov-2 antigen nanoparticles and uses there of
F Borriello, O Levy, DJ Dowling… - US Patent App. 18 …, 2024 - Google Patents
2024-01-16 Assigned to CHILDREN'S MEDICAL CENTER CORPORATION reassignment
CHILDREN'S MEDICAL CENTER CORPORATION ASSIGNMENT OF ASSIGNORS …
CHILDREN'S MEDICAL CENTER CORPORATION ASSIGNMENT OF ASSIGNORS …
Adjuvants for severe acute respiratory syndrome-related coronavirus (sars-cov) vaccines
DJ Dowling, O Levy, F Borriello, E Nanishi… - US Patent App. 17 …, 2023 - Google Patents
US20230201340A1 - Adjuvants for severe acute respiratory syndrome-related coronavirus (sars-cov)
vaccines - Google Patents US20230201340A1 - Adjuvants for severe acute respiratory …
vaccines - Google Patents US20230201340A1 - Adjuvants for severe acute respiratory …